Today's Analyst Stock Ratings | Upgrades, Downgrades

							Get Alert
Aug 11, 2026	ACGLArch Capital Group	$96.81	2.26%	Meyer ShieldsKeefe, Bruyette & Woods 75%	99 99	Previous Market Perform Current Market Perform	Get Alert
Aug 11, 2026	ACGLArch Capital Group	$96.81	21.89%	Pablo SingzonJP Morgan 68%	116 118	Previous Neutral Current Neutral	Get Alert
Aug 5, 2026	ACGLArch Capital Group	$96.81	5.36%	Michael ZaremskiBMO Capital 63%	95 102	Previous Market Perform Current Market Perform	Get Alert
Aug 3, 2026	ACGLArch Capital Group	$96.81	14.66%	Bob HuangMorgan Stanley 55%	110 111	Previous Overweight Current Overweight	Get Alert
Aug 3, 2026	ACGLArch Capital Group	$96.81	13.62%	Ryan TunisCantor Fitzgerald 58%	102 110	Previous Neutral Current Neutral	Get Alert
Jul 30, 2026	ACGLArch Capital Group	$96.81	23.95%	Rowland MayorRBC Capital 58%	115 120	Previous Outperform Current Outperform	Get Alert
Jul 30, 2026	ACGLArch Capital Group	$96.81	20.86%	Elyse GreenspanWells Fargo 71%	114 117	Previous Overweight Current Overweight	Get Alert
Jul 29, 2026	ACGLArch Capital Group	$96.81	13.62%	Harry FongRoth Capital 69%	110 110	Previous Buy Current Buy	Get Alert
Jul 29, 2026	ACGLArch Capital Group	$96.81	38.42%	Joshua ShankerB of A Securities 69%	126 134	Previous Buy Current Buy	Get Alert
Jul 20, 2026	ACGLArch Capital Group	$96.81	19.82%	Pablo SingzonJP Morgan 68%	110 116	Previous Neutral Current Neutral	Get Alert
Jul 13, 2026	ACGLArch Capital Group	$96.81	7.43%	Yaron KinarMizuho 69%	104 104	Previous Neutral Current Neutral	Get Alert
Jul 9, 2026	ACGLArch Capital Group	$96.81	17.76%	Elyse GreenspanWells Fargo 71%	110 114	Previous Overweight Current Overweight	Get Alert
Jul 9, 2026	ACGLArch Capital Group	$96.81	5.36%	Ryan TunisCantor Fitzgerald 58%	100 102	Previous Neutral Current Neutral	Get Alert
Jul 9, 2026	ACGLArch Capital Group	$96.81	7.43%	Yaron KinarMizuho 69%	101 104	Previous Neutral Current Neutral	Get Alert
Jul 8, 2026	ACGLArch Capital Group	$96.81	23.95%	Brian MeredithUBS 74%	114 120	Previous Buy Current Buy	Get Alert
Jul 8, 2026	ACGLArch Capital Group	$96.81	2.26%	Meyer ShieldsKeefe, Bruyette & Woods 75%	99 102	Previous Market Perform Current Market Perform	Get Alert
Jul 7, 2026	ACGLArch Capital Group	$96.81	9.49%	Alex ScottBarclays 67%	106 106	Previous Equal-Weight Current Equal-Weight	Get Alert
Jul 6, 2026	ACGLArch Capital Group	$96.81	13.62%	Bob HuangMorgan Stanley 55%	105 110	Previous Overweight Current Overweight	Get Alert
May 5, 2026	ACGLArch Capital Group	$96.81	5.36%	Meyer ShieldsKeefe, Bruyette & Woods 75%	102 105	Previous Market Perform Current Market Perform	Get Alert
May 5, 2026	ACGLArch Capital Group	$96.81	4.33%	Yaron KinarMizuho 69%	101 102	Previous Neutral Current Neutral	Get Alert
Apr 30, 2026	ACGLArch Capital Group	$96.81	26.54%	Matthew HeimermannCitigroup 58%	120 122.5	Previous Buy Current Buy	Get Alert
Apr 30, 2026	ACGLArch Capital Group	$96.81	13.62%	Elyse GreenspanWells Fargo 71%	109 110	Previous Overweight Current Overweight	Get Alert
Apr 20, 2026	ACGLArch Capital Group	$96.81	13.62%	Jimmy BhullarJP Morgan 63%	110 117	Previous Neutral Current Neutral	Get Alert
Apr 8, 2026	ACGLArch Capital Group	$96.81	9.49%	Alex ScottBarclays 67%	104 106	Previous Equal-Weight Current Equal-Weight	Get Alert
Apr 7, 2026	ACGLArch Capital Group	$96.81	8.46%	Meyer ShieldsKeefe, Bruyette & Woods 75%	104 105	Previous Market Perform Current Market Perform	Get Alert
Feb 17, 2026	ACGLArch Capital Group	$96.81	17.76%	Brian MeredithUBS 74%	113 114	Previous Buy Current Buy	Get Alert
Feb 17, 2026	ACGLArch Capital Group	$96.81	3.3%	Ryan TunisCantor Fitzgerald 58%	97 100	Previous Neutral Current Neutral	Get Alert
Feb 13, 2026	ACGLArch Capital Group	$96.81	23.95%	Matthew HeimermannCitigroup 58%	113 120	Previous Buy Current Buy	Get Alert
Feb 13, 2026	ACGLArch Capital Group	$96.81	7.43%	Meyer ShieldsKeefe, Bruyette & Woods 75%	102 104	Previous Market Perform Current Market Perform	Get Alert
Feb 12, 2026	ACGLArch Capital Group	$96.81	5.36%	Yaron KinarMizuho 69%	95 102	Previous Neutral Current Neutral	Get Alert
Feb 11, 2026	ACGLArch Capital Group	$96.81	18.79%	Rowland MayorRBC Capital 58%	108 115	Previous Outperform Current Outperform	Get Alert
Feb 11, 2026	ACGLArch Capital Group	$96.81	12.59%	Elyse GreenspanWells Fargo 71%	106 109	Previous Overweight Current Overweight	Get Alert
Jan 14, 2026	ACGLArch Capital Group	$96.81	0.2%	Ryan TunisCantor Fitzgerald 58%	93 97	Previous Neutral Current Neutral	Get Alert
Jan 8, 2026	ACGLArch Capital Group	$96.81	7.43%	Alex ScottBarclays 67%	99 104	Previous Equal-Weight Current Equal-Weight	Get Alert
Jan 8, 2026	ACGLArch Capital Group	$96.81	-3.94%	Robert CoxGoldman Sachs 50%	84 93	Previous Sell Current Sell	Get Alert
Jan 7, 2026	ACGLArch Capital Group	$96.81	3.3%	David MotemadenEvercore ISI Group 60%	97 100	Previous In-Line Current In-Line	Get Alert
Jan 7, 2026	ACGLArch Capital Group	$96.81	20.86%	Jimmy BhullarJP Morgan 63%	111 117	Previous Neutral Current Neutral	Get Alert
Jan 6, 2026	ACGLArch Capital Group	$96.81	5.36%	Meyer ShieldsKeefe, Bruyette & Woods 75%	100 102	Previous Market Perform Current Market Perform	Get Alert
Dec 16, 2025	ACGLArch Capital Group	$96.81	-1.87%	Yaron KinarMizuho 69%	95	Previous Initiates Current Neutral	Get Alert
Dec 2, 2025	ACGLArch Capital Group	$96.81	13.62%	Harry FongRoth Capital 69%	110 125	Previous Buy Current Buy	Get Alert
Nov 25, 2025	ACGLArch Capital Group	$96.81	11.56%	Rowland MayorRBC Capital 58%	108	Previous Current Outperform	Get Alert
Nov 17, 2025	ACGLArch Capital Group	$96.81	13.62%	Michael PhillipsMorgan Stanley 56%	105 110	Previous Overweight Current Overweight	Get Alert
Oct 29, 2025	ACGLArch Capital Group	$96.81	9.49%	Elyse GreenspanWells Fargo 71%	106 111	Previous Overweight Current Overweight	Get Alert
Oct 28, 2025	ACGLArch Capital Group	$96.81	14.66%	Jimmy BhullarJP Morgan 63%	110 111	Previous Neutral Current Neutral	Get Alert
Oct 14, 2025	ACGLArch Capital Group	$96.81	-9.1%	Robert CoxGoldman Sachs 50%	88	Previous Initiates Current Sell	Get Alert
Oct 8, 2025	ACGLArch Capital Group	$96.81	2.26%	Alex ScottBarclays 67%	93 99	Previous Equal-Weight Current Equal-Weight	Get Alert
Oct 8, 2025	ACGLArch Capital Group	$96.81	14.66%	Elyse GreenspanWells Fargo 71%	107 111	Previous Overweight Current Overweight	Get Alert
Sep 16, 2025	ACGLArch Capital Group	$96.81	—	Tracy BenguiguiWolfe Research 59%	—	Previous Initiates Current Peer Perform	Get Alert
Aug 14, 2025	ACGLArch Capital Group	$96.81	6.39%	Meyer ShieldsKeefe, Bruyette & Woods 75%	102 103	Previous Market Perform Current Market Perform	Get Alert
Aug 13, 2025	ACGLArch Capital Group	$96.81	16.72%	Matthew HeimermannCitigroup 58%	113	Previous Initiates Current Buy	Get Alert
Aug 5, 2025	ACGLArch Capital Group	$96.81	5.36%	Meyer ShieldsKeefe, Bruyette & Woods 75%	101 102	Previous Market Perform Current Market Perform	Get Alert
Aug 4, 2025	ACGLArch Capital Group	$96.81	21.89%	Brian MeredithUBS 74%	118 124	Previous Buy Current Buy	Get Alert
Jul 31, 2025	ACGLArch Capital Group	$96.81	10.53%	Elyse GreenspanWells Fargo 71%	107 110	Previous Overweight Current Overweight	Get Alert
Jul 14, 2025	ACGLArch Capital Group	$96.81	13.62%	Jimmy BhullarJP Morgan 63%	107 110	Previous Neutral Current Neutral	Get Alert
Jul 10, 2025	ACGLArch Capital Group	$96.81	13.62%	Elyse GreenspanWells Fargo 71%	108 110	Previous Overweight Current Overweight	Get Alert
Jul 9, 2025	ACGLArch Capital Group	$96.81	4.33%	Meyer ShieldsKeefe, Bruyette & Woods 75%	101 113	Previous Outperform Current Market Perform	Get Alert
Jun 10, 2025	ACGLArch Capital Group	$96.81	3.3%	Yaron KinarJefferies 69%	100 106	Previous Buy Current Hold	Get Alert
May 19, 2025	ACGLArch Capital Group	$96.81	13.62%	Michael PhillipsMorgan Stanley 56%	105 110	Previous Overweight Current Overweight	Get Alert
May 6, 2025	ACGLArch Capital Group	$96.81	16.72%	Meyer ShieldsKeefe, Bruyette & Woods 75%	104 113	Previous Outperform Current Outperform	Get Alert
May 1, 2025	ACGLArch Capital Group	$96.81	11.56%	Elyse GreenspanWells Fargo 71%	106 108	Previous Overweight Current Overweight	Get Alert
Apr 30, 2025	ACGLArch Capital Group	$96.81	29.12%	Matthew CarlettiJMP Securities 81%	125 125	Previous Market Outperform Current Market Outperform	Get Alert
Apr 11, 2025	ACGLArch Capital Group	$96.81	-3.94%	Alex ScottBarclays 67%	93 100	Previous Equal-Weight Current Equal-Weight	Get Alert
Apr 11, 2025	ACGLArch Capital Group	$96.81	9.49%	Yaron KinarJefferies 69%	105 106	Previous Buy Current Buy	Get Alert
Apr 10, 2025	ACGLArch Capital Group	$96.81	8.46%	Michael PhillipsMorgan Stanley 56%	105 110	Previous Overweight Current Overweight	Get Alert
Apr 9, 2025	ACGLArch Capital Group	$96.81	7.43%	Meyer ShieldsKeefe, Bruyette & Woods 75%	104 113	Previous Outperform Current Outperform	Get Alert
Apr 9, 2025	ACGLArch Capital Group	$96.81	28.09%	Brian MeredithUBS 74%	124 127	Previous Buy Current Buy	Get Alert
Apr 8, 2025	ACGLArch Capital Group	$96.81	10.53%	Jimmy BhullarJP Morgan 63%	106 107	Previous Neutral Current Neutral	Get Alert
Feb 18, 2025	ACGLArch Capital Group	$96.81	31.18%	Brian MeredithUBS 74%	127 131	Previous Buy Current Buy	Get Alert
Feb 14, 2025	ACGLArch Capital Group	$96.81	13.62%	Michael PhillipsMorgan Stanley 56%	110 115	Previous Overweight Current Overweight	Get Alert
Feb 13, 2025	ACGLArch Capital Group	$96.81	8.46%	Yaron KinarJefferies 69%	105 107	Previous Buy Current Buy	Get Alert
Feb 13, 2025	ACGLArch Capital Group	$96.81	16.72%	Meyer ShieldsKeefe, Bruyette & Woods 75%	113 120	Previous Outperform Current Outperform	Get Alert
Feb 12, 2025	ACGLArch Capital Group	$96.81	13.62%	Scott HeleniakRBC Capital 70%	110 125	Previous Outperform Current Outperform	Get Alert
Feb 12, 2025	ACGLArch Capital Group	$96.81	9.49%	Elyse GreenspanWells Fargo 71%	106 107	Previous Overweight Current Overweight	Get Alert
Feb 11, 2025	ACGLArch Capital Group	$96.81	29.12%	Matthew CarlettiJMP Securities 81%	125 125	Previous Market Outperform Current Market Outperform	Get Alert
Jan 14, 2025	ACGLArch Capital Group	$96.81	10.53%	Elyse GreenspanWells Fargo 71%	107 109	Previous Overweight Current Overweight	Get Alert
Jan 10, 2025	ACGLArch Capital Group	$96.81	23.95%	Meyer ShieldsKeefe, Bruyette & Woods 75%	120 121	Previous Outperform Current Outperform	Get Alert
Jan 6, 2025	ACGLArch Capital Group	$96.81	3.3%	Alex ScottBarclays 67%	100 120	Previous Equal-Weight Current Equal-Weight	Get Alert
Jan 3, 2025	ACGLArch Capital Group	$96.81	9.49%	Jimmy BhullarJP Morgan 63%	106 110	Previous Neutral Current Neutral	Get Alert
Dec 20, 2024	ACGLArch Capital Group	$96.81	10.53%	Yaron KinarJefferies 69%	107 134	Previous Buy Current Buy	Get Alert
Nov 19, 2024	ACGLArch Capital Group	$96.81	12.59%	Elyse GreenspanWells Fargo 71%	109 118	Previous Overweight Current Overweight	Get Alert
Nov 15, 2024	ACGLArch Capital Group	$96.81	40.48%	Jay CohenB of A Securities 48%	136 143	Previous Buy Current Buy	Get Alert
Nov 6, 2024	ACGLArch Capital Group	$96.81	7.43%	Michael ZaremskiBMO Capital 63%	98 104	Previous Market Perform Current Market Perform	Get Alert
Nov 4, 2024	ACGLArch Capital Group	$96.81	21.89%	Elyse GreenspanWells Fargo 71%	118 126	Previous Overweight Current Overweight	Get Alert
Nov 1, 2024	ACGLArch Capital Group	$96.81	29.12%	Scott HeleniakRBC Capital 70%	125 128	Previous Outperform Current Outperform	Get Alert
Oct 15, 2024	ACGLArch Capital Group	$96.81	29.12%	Matthew CarlettiJMP Securities 81%	115 125	Previous Market Outperform Current Market Outperform	Get Alert
Oct 10, 2024	ACGLArch Capital Group	$96.81	13.62%	Jimmy BhullarJP Morgan 63%	108 110	Previous Neutral Current Neutral	Get Alert
Oct 10, 2024	ACGLArch Capital Group	$96.81	39.45%	Jay CohenB of A Securities 48%	119 135	Previous Buy Current Buy	Get Alert
Oct 10, 2024	ACGLArch Capital Group	$96.81	30.15%	Elyse GreenspanWells Fargo 71%	110 126	Previous Overweight Current Overweight	Get Alert
Oct 9, 2024	ACGLArch Capital Group	$96.81	35.32%	Brian MeredithUBS 74%	114 131	Previous Buy Current Buy	Get Alert
Oct 9, 2024	ACGLArch Capital Group	$96.81	38.42%	Yaron KinarJefferies 69%	114 134	Previous Buy Current Buy	Get Alert
Oct 9, 2024	ACGLArch Capital Group	$96.81	10.53%	David MotemadenEvercore ISI Group 60%	104 107	Previous In-Line Current In-Line	Get Alert
Oct 3, 2024	ACGLArch Capital Group	$96.81	32.22%	Scott HeleniakRBC Capital 70%	112 128	Previous Outperform Current Outperform	Get Alert
Sep 20, 2024	ACGLArch Capital Group	$96.81	42.55%	Andrew KligermanTD Cowen 68%	116 138	Previous Buy Current Buy	Get Alert
Sep 10, 2024	ACGLArch Capital Group	$96.81	17.76%	Charlie LedererCitigroup 40%	105 114	Previous Neutral Current Neutral	Get Alert
Sep 4, 2024	ACGLArch Capital Group	$96.81	23.95%	Alex ScottBarclays 67%	120	Previous Initiates Current Equal-Weight	Get Alert
Aug 24, 2024	ACGLArch Capital Group	$96.81	1.23%	Michael ZaremskiBMO Capital 63%	94 98	Previous Market Perform Current Market Perform	Get Alert
Aug 23, 2024	ACGLArch Capital Group	$96.81	29.12%	Harry FongRoth MKM 69%	110 125	Previous Buy Current Buy	Get Alert
Aug 12, 2024	ACGLArch Capital Group	$96.81	13.62%	Elyse GreenspanWells Fargo 71%	110 111	Previous Overweight Current Overweight	Get Alert
Aug 7, 2024	ACGLArch Capital Group	$96.81	24.99%	Meyer ShieldsKeefe, Bruyette & Woods 75%	120 121	Previous Outperform Current Outperform	Get Alert
Aug 5, 2024	ACGLArch Capital Group	$96.81	17.76%	Brian MeredithUBS 74%	110 114	Previous Buy Current Buy	Get Alert

Recent Analyst Stock Rating News

PRO

Needham Reiterates Buy on BioCryst Pharma, Maintains $16 Price Target

Needham analyst Serge Belanger reiterates BioCryst Pharma (NASDAQ:BCRX) with a Buy and maintains $16 price target.

PRO

HC Wainwright & Co. Maintains Buy on PDS Biotechnology, Lowers Price Target to $5

HC Wainwright & Co. analyst Joseph Pantginis maintains PDS Biotechnology (NASDAQ:PDSB) with a Buy and lowers the price target from $7 to $5.

PRO

HC Wainwright & Co. Maintains Buy on Sernova Biotherapeutics, Lowers Price Target to C$1

HC Wainwright & Co. analyst Joseph Pantginis maintains Sernova Biotherapeutics (TSX:SVA) with a Buy and lowers the price target from C$6 to C$1.

PRO

CNBC Halftime Report Final Trades: Freeport-McMoRan, Pinnacle Financial Partners, Cheniere Energy

PRO

UBS Maintains Neutral on Quest Diagnostics, Raises Price Target to $245

UBS analyst Kevin Caliendo maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $232 to $245.

PRO

Oppenheimer Maintains Outperform on Target Hospitality, Raises Price Target to $27

Oppenheimer analyst Scott Schneeberger maintains Target Hospitality (NASDAQ:TH) with a Outperform and raises the price target from $24 to $27.

PRO

Citigroup Maintains Neutral on Harley-Davidson, Raises Price Target to $31

Citigroup analyst James Hardiman maintains Harley-Davidson (NYSE:HOG) with a Neutral and raises the price target from $27 to $31.

PRO

Oppenheimer Maintains Outperform on Climb Bio, Raises Price Target to $25

Oppenheimer analyst Leland Gershell maintains Climb Bio (NASDAQ:CLYM) with a Outperform and raises the price target from $18 to $25.

PRO

Truist Securities Reiterates Buy on Arcus Biosciences, Raises Price Target to $40

Truist Securities analyst Supawat Thongthip reiterates Arcus Biosciences (NYSE:RCUS) with a Buy and raises the price target from $35 to $40.

PRO

Citigroup Maintains Buy on Saia, Lowers Price Target to $417

Citigroup analyst Ariel Rosa maintains Saia (NASDAQ:SAIA) with a Buy and lowers the price target from $423 to $417.

The Best Trading Research Platform

For Retail Investors and Professional Trades Alike.

Get Started for Free

What Are Analyst Stock Ratings?

Analyst ratings measure the expected performance of a stock during a given time period. Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders.

Analysts arrive at stock ratings after they research companies’ public financial statements, communicate with executives and customers and interact with companies in other ways.

Most analysts issue ratings 4 times a year, usually at 3-month intervals.

How to Use Analyst Ratings

As an investor or trader, you want to be able to use analyst ratings effectively. Here are steps you can take to understand how to synthesize all the information analysts report about a particular company and how to apply it to your own trades.

Step 1: Check Ratings History

In the short term, look to see whether analysts suggest an initiation, upgrade or downgrade for a particular stock. Understand how the rating changed compared to the previous rating and whether a price target gets announced or changed.

Sometimes the rating stays the same and only the price target changes, which could cause the stock to move in either direction, depending on the significance of the change between the 2 price targets.

Step 2: Check for Other News

In the short term, check to see how the stock reacts to positive or negative news. This will be an indication of the company’s outlook because analyst ratings usually come out after the company announces news (it’ll typically be earnings news).

Step 3: Look at the Sector for News

Check to see if other stocks in the sector also received similar ratings. This could indicate micro news, which refers to when the whole sector or specific company trades in a specific way due to news outside of one company.

Step 4: Look at the Note

If available, look over the analyst note itself. The beginning of the note has the main information of the rating and price target. Investors should also take a look at the summary of the note, which you can find in the first couple pages and give you a concrete overview of the company. This can help you get an understanding of how analysts arrived at their thesis on the stock.

An example of an analyst note. Source: Needham

Step 5: Make a Decision

After reviewing the analyst ratings (and whether the analyst proposes a change or initiation) and find the reason for that note. Make a decision based on the analyst thesis on the company. This should give you guidance on how to make your thesis. Analyst ratings are a good indication of what professionals believe the company or sector will do, helping you get a better understanding of the companies you’re interested in.

Analyst Rating Accuracy

Analyst ratings are not set in stone and nobody knows indefinitely what a stock will do. Therefore, analyst ratings should be taken as an educated guess made by professionals who carefully study the specific company and sector in question. It's not a surprise that the accuracy of each rating can vary by each individual analyst and specific ratings on companies.

In other words, there’s no hard number or percentage on how accurate analyst ratings are because they are like educated guesses on what they think the stock will do based on their research, within that particular sector. In addition, each firm has so many analysts and so many different companies to review that you can compare ratings to glean what you believe is the truth.

Where Analyst Ratings Come From

Analyst ratings come from stock analysts. Analysts “go deep” on companies within a particular industry or sector. Some analysts employ a top-down approach (they start with an industry or sector and look for excellent companies within that industry or sector) and other stock analysts choose a bottom-up approach, which means they start with the company first and connect the dots within that company’s sector or industry. Analysts evaluate:

Financial statements
Economic fundamentals
Suppliers, customers and competitors
Management quality
Business model
Revenue
Expenses
Assets
Liabilities

While these evaluations are done using facts and figures that any investor can access, they come down to a conclusion the analyst must draw. While this isn’t an unqualified opinion, analysts will disagree because their interpretations of the data could vary.

Types of Stock Ratings

Stock ratings can range from simple “buy” and “sell” ratings to “equal weight” and “outperform” ratings. Here’s a quick overview of how analysts rate stocks.

Buy Rating

A “buy” rating indicates that an analyst is optimistic about a stock’s short-term or mid-term growth and recommends that traders purchase the stock. An analyst may even go so far as to indicate that a stock is a “strong buy.” At the same time, you may choose to swing trade the asset for a profit and come back later to start the process all over again.

Sell Rating

A “sell” rating means that an analyst believes the stock will trend downward in a particular time frame. Analysts might even refer to a security as a “strong sell.” Remember, though, you may want to swing trade and come back to this asset in the future even though you just chose to sell, just as you would under a “buy” rating.

Hold

A “hold” rating suggests that investors should not buy more of or sell the specified stock because they believe the stock should perform in a way that’s consistent with the market or will perform similarly to comparable companies within that particular sector. This is akin to the value investing approach that Warren Buffett uses, looking to gain long-term value from a single stock rather than flipping it because of a bad week. As many have said, it’s not a loss until you sell.

Underperform

An “underperform” rating means an analyst indicates that a stock is expected to perform below the market or sector average. And yes, while the underperform rating may not bode well for an asset in the next few weeks, it may not stay that way. Continue to carefully monitor your portfolio to ensure that an underperforming asset hasn’t turned itself around. As companies are faced with the Herculean task of pleasing shareholders, they will push to fix their underperforming stocks, meaning that a stock you wrote off could rise again.

Outperform

An “outperform” rating means that an analyst expects a stock to outperform the market or sector average. While the stock may look to outperform the market or a sector’s average, that doesn’t mean it will continue to soar forever. You must look at an outperform rating as what that asset will do in recent times, but it may not maintain that trajectory.

Equal-Weight

An equal weight rating means that an analyst believes that an individual stock's performance will tie to the average of all the stocks that an analyst covers in that particular sector. This type of rating helps investors get a true comparison of stocks to each other within a particular sector or industry. At the same time, equal-weight ratings could change at any time.

Price Target

A price target is an analyst’s projection of a stock’s future price. A price target is generally set up in a general trade or area where the asset might land. This means that the analyst could get close without hitting the figure on the head. Even so, the analyst wants to get close and better predict the movement of the marketplace and the asset.

Understanding Stock Ratings

Stock ratings are assessments of the investment potential of a particular stock. They are typically created by financial analysts who evaluate a company's financial performance, competitive positioning, and market outlook to provide guidance on the stock's expected future performance.

Ratings typically range from "buy" to "sell," with variations in between, such as "hold," "accumulate," or "neutral." A "buy" rating suggests that the stock is likely to perform well in the future, and investors should consider purchasing it. Conversely, a "sell" rating indicates that the stock is expected to underperform, and investors should consider selling it.

It's important to note that ratings are not guarantees of performance and should not be relied upon solely when making investment decisions. Ratings are just one factor to consider when evaluating a stock's potential, and investors should also conduct their own research and analysis to make informed decisions.

Another thing to keep in mind is that different analysts may have different opinions on a stock, so it's a good idea to consider multiple ratings before making an investment decision.

In addition to analyst ratings, investors can also consider other factors when evaluating a stock, such as its financial statements, management team, industry trends, and overall market conditions. By combining all of these factors, investors can make informed decisions about which stocks to buy or sell.

In summary, stock ratings are an important tool for investors to consider when evaluating a stock's potential, but they should not be the only factor used in investment decision-making. It's important to conduct your own research, consider multiple ratings, and take into account other factors before making an investment decision.

Should You Use Analyst Ratings to Inform Your Own Trades?

You can definitely use analyst ratings to inform your own trades and inform your own thesis but it’s a good idea to do your own research. However, analyst ratings are just one step in what should be a much larger investment strategy. Don’t fall in love with just one analyst. Compare notes. Look into how these ratings match with activity on the market and current events. Plus, remember that an analyst rating could easily be incorrect. No one is perfect, but these ratings are a good place to start.

Visit Benzinga News for more guidance on how to research companies and make decisions about research, trading and investing.

Compare Online Stock Brokers

Claim Exclusive Offers

Interactive Brokers Review
Good Fit For:
Active and Global Traders
VIEW PROS & CONS:
Securely through Interactive Brokers’ website
Plus500 Review
Good Fit For:
Leveraged Trading
VIEW PROS & CONS:
securely through Plus500 Yield's website
public.com Review
Good Fit For:
Trading Ideas
VIEW PROS & CONS:
securely through public.com's website
Robinhood Review
Good Fit For:
Commission-Free Mobile Trading
VIEW PROS & CONS:
securely through Robinhood's website
TradeZero Review
Good Fit For:
Active Short Sellers
VIEW PROS & CONS:
securely through TradeZero [SPONSORED]'s website